Gelatin‐Based Electrospun Nanofibrous Membranes for Treatment of Intrauterine Adhesion
The FASEB Journal · 2026
DOI: 10.1096/fj.202603136r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Houjin Dongye und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive H…. Hauptthemen laut MEDLINE: Gelatin, Nanofibers, Uterine Diseases. Die Arbeit nennt 38 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Key Research and Development Program of Shandong Province, China.
Abstract (Originalsprache)
As the leading cause of uterine factor infertility, intrauterine adhesion (IUA) poses a severe threat to the fertility and mental health of women at childbearing age. However, the efficacy of the present clinical treatments is unsatisfactory. There remains an urgent need to develop a safe, effective, and clinically feasible therapeutic strategy to restore the damaged endometrium. Here, we fabricated a gelatin‐based electrospun nanofibrous membrane (GENM) via electrospinning and chemical crosslinking technique and characterized its properties. The anti‐fibrotic and pro‐angiogenic effects of GENM were evaluated in cellular models. A rat IUA model induced by mechanical scraping was established to assess the therapeutic efficacy of GENM by histological staining. Additionally, bulk RNA sequencing was performed to explore the underlying mechanisms. Our results demonstrated GENM inhibited transforming growth factor beta 1 (TGF‐β1) induced fibrosis in human endometrial stromal cells (HESCs) and promoted angiogenesis of human umbilical vein endothelial cells (HUVECs). Animal experiments also suggested that GENM significantly improved endometrial receptivity and neovascularization while reducing fibrosis in the rat IUA model. RNA sequencing further identified several signaling pathways contributing to uncovering its mechanism of action. These findings indicate that GENM holds significant potential for clinical application in the management of IUA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, Shandong, China.
- National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, Jinan, Shandong, China.
- Key Laboratory of Reproductive Endocrinology (Shandong University), Ministry of Education, Jinan, Shandong, China.
- Shandong Technology Innovation Center for Reproductive Health, Jinan, Shandong, China.
- Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, Shandong, China.
- Shandong Key Laboratory of Reproductive Research and Birth Defect Prevention, Jinan, Shandong, China.
ORCID-Profile: Houjin Dongye, Lei Yan
Förderung
- National Key Research and Development Program of China
- Key Research and Development Program of Shandong Province, China
Zitieren
APA
Dongye, H., Wu, Y., Hu, J., Lv, C., Wang, Y., Gai, M., Sa, S., Zhang, W., Li, M., Zhu, X., Wei, K., Zhao, R., & Yan, L. (2026). Gelatin‐Based Electrospun Nanofibrous Membranes for Treatment of Intrauterine Adhesion. The FASEB Journal. https://doi.org/10.1096/fj.202603136r
Vancouver
Dongye H, Wu Y, Hu J, Lv C, Wang Y, Gai M, et al. Gelatin‐Based Electrospun Nanofibrous Membranes for Treatment of Intrauterine Adhesion. The FASEB Journal. 2026. doi:10.1096/fj.202603136r
BibTeX
@article{Dongye2026,
author = {Dongye, Houjin and Wu, Yuxiu and Hu, Jie and Lv, Chen and Wang, Yuqing and Gai, Minxue and Sa, Shawei and Zhang, Wencai and Li, Ming and Zhu, Xiaoqiang and Wei, Keke and Zhao, Rusong and Yan, Lei},
title = {Gelatin‐Based Electrospun Nanofibrous Membranes for Treatment of Intrauterine Adhesion},
journal = {The FASEB Journal},
year = {2026},
doi = {10.1096/fj.202603136r}
}
EUVIMED